EWM
MGNX icon

Endurance Wealth Management’s MacroGenics MGNX Stock Holding History

Endurance Wealth Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$2K – 528
2015
Q3 		$2K Hold
100
– – ﹤0.01% 485
2015
Q2 		$4K Buy
+100
New +$3.29K ﹤0.01% 462

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Endurance Wealth Management's MGNX Position: Q4 2015 in Review

Endurance Wealth Management sold out of MacroGenics (MGNX) in Q4 2015, closing a stake of 100 shares — an estimated $2K sold.

Endurance Wealth Management first reported a position in MGNX in Q2 2015 and held it in 2 quarters. The position peaked at $4K in Q2 2015. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2015.

  • Endurance Wealth Management reported no remaining MacroGenics position as of Q4 2015 after selling out during the quarter.
  • Endurance Wealth Management sold 100 MacroGenics shares in Q4 2015, an estimated $2K.
  • Endurance Wealth Management first reported a position in MacroGenics in Q2 2015 and held it in 2 quarters.
  • Endurance Wealth Management's MacroGenics position peaked at $4K in Q2 2015.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2015.

Based on Endurance Wealth Management's 13F filing for Q4 2015, filed 27 Jan 2016.